TriveniBio
PrivateLast Round
Series C
Jun 17, 2026
Est. Valuation
$390.53M
Total Funding Raised
$272M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
TriveniBio is a clinical-stage biotechnology company developing antibody-based therapies for immunological and inflammatory disorders.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TriveniBio Comps
Public and private peers based on sector, stage, and business model.
TriveniBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 17, 2026 | ||||
| Series B | Oct 2, 2024 | ||||
| Series A | Oct 26, 2023 |
TriveniBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series C |
| Fidelity Management & Research Company | Series B |
| Deep Track Capital | Series C, Series B |
| OrbiMed | Series B, Series A |
| Invus Opportunities | Series B, Series A |
| Viking Global Investors | Series B, Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
$65M round led by Janus Henderson Group and Ascenta Capital.
- Oct 2, 2024
$115M round led by Goldman Sachs Alternatives.
TriveniBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TriveniBio's valuation, stock price, and market status.
